Monday, November 16, 2026Sign in
The Global Chalet news hub

‹ News

biohacking

Precision Neuroscience Expands Layer 7 Cortical Brain-Computer Interface Trials to Cleveland Clinic Abu Dhabi

Confirmed·
Photo: neurofounders.co

Following its $250 million Series D funding round, brain-computer interface developer Precision Neuroscience has signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi (CCAD) and Abu Dhabi's Department of Health to launch its first international clinical study site, Neurofounders' Yael Lissack reported on November 9, 2026.

The international study will evaluate Precision's FDA-cleared Layer 7 Cortical Interface—a postage-stamp-sized thin-film array packing 1,024 surface electrodes that read electrical signals from the cerebral cortex without penetrating brain tissue. Cleared by the U.S. Food and Drug Administration in 2025 for temporary monitoring of up to 30 days, Layer 7 will be tested at CCAD in two adult neurosurgical cohorts: intraoperative brain mapping during surgery and post-operative hospital monitoring stays of up to 30 days.

Chief Clinical Officer Jayme Strauss told Neurofounders that Precision has already assembled a neural-activity atlas from 70 U.S. patients and is using the multi-country clinical data to prepare for a future Class III chronic permanent-implant trial.

Where this came from
neurofounders.co · Read the original ↗
We write a short summary in our own words. The original has the full story.

More about biohacking